Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > talk to the CEO

<< Previous

Bullboard Posts

Next >>

Comment by WarrantOfficeron Jan 04, 2023 7:26pm

148 Views

Post# 35203916

RE:RE:RE:talk to the CEO

Brent spoke on Raincage. He explained the fullerene technology and the zero emmsion production facility. Nothing stated that was not already known. He spoke of the additional barite products, stated they were in development stage, with projected barite sales revenue in 100 - 200M, with iodine sales at multiples of barite. They have a new Canadian West sales manager, seeking one for the East. Project mining processing costs of 500 ton.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?